Literature DB >> 12714198

Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users.

Qingyi Meng1, Joao A Lima, Hong Lai, David Vlahov, David D Celentano, Joseph B Margolick, S Lai.   

Abstract

OBJECTIVE: To examine the relationship of the serum C-reactive protein (CRP) and endothelial function and their associations with coronary artery calcification, lipid profile and cardiac changes.
METHODS: The analyses for serum lipids and CRP, echocardiography, spiral computed tomography scans and endothelial function assay were performed in 53 participants with a history of chronic cocaine use.
RESULTS: There were no statistically significant differences in demographic characteristics and drug use between CRP normal (<1.9 mg/l) and abnormal groups. The brachial artery diameter percentage changes in the third scan (immediately after deflation of cuff) and the fourth scan (90 s after deflation of cuff) were significantly associated with the CRP levels (the third: beta=-0.054, S.E.=0.027; P=0.028; the fourth: beta=-0.065, S.E.=0.026; P=0.016). The multiple regression models showed that CRP was the only significant predictor of artery diameter changes (%) in these two scans. The CRP abnormal group had more coronary artery calcification (calcium scores >5, 16.7 vs. 0%; P=0.036) and more cardiac diastolic dysfunction expressed as deceleration time >240 ms (16.7 vs. 0%; P=0.036).
CONCLUSIONS: Elevated serum CRP levels are associated with endothelial dysfunction, coronary artery calcification and cardiac diastolic dysfunction in chronic cocaine users.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714198     DOI: 10.1016/s0167-5273(02)00394-7

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

1.  Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection.

Authors:  Hong Lai; Gary Gerstenblith; Elliot K Fishman; Jeffrey Brinker; Thomas Kickler; Wenjing Tong; Sundeepan Bhatia; Tai Hong; Shaoguang Chen; Ji Li; Barbara Detrick; Shenghan Lai
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

2.  HIV infection and cocaine use induce endothelial damage and dysfunction in African Americans.

Authors:  Hong Tai; Hong Lai; Jayesh Jani; Shenghan Lai; Thomas S Kickler
Journal:  Int J Cardiol       Date:  2011-05-19       Impact factor: 4.164

3.  Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung.

Authors:  Xuefeng Zhang; Susan Jiang; Jinlong Yu; Paula M Kuzontkoski; Jerome E Groopman
Journal:  Physiol Rep       Date:  2015-08

4.  Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection.

Authors:  Shenghan Lai; Elliot K Fishman; Gary Gerstenblith; Jeffrey Brinker; Hong Tai; Shaoguang Chen; Ji Li; Wenjing Tong; Barbara Detrick; Hong Lai
Journal:  Vasc Health Risk Manag       Date:  2013-08-26

5.  Circulating miR-126 and miR-499 reflect progression of cardiovascular disease; correlations with uric acid and ejection fraction.

Authors:  Masoud Khanaghaei; Fereshtah Tourkianvalashani; Seyedhossein Hekmatimoghaddam; Nasrin Ghasemi; Mahdi Rahaie; Vahid Khorramshahi; Akhtar Sheikhpour; Zahra Heydari; Fatemeh Pourrajab
Journal:  Heart Int       Date:  2016-04-26

6.  Aberrant disgust responses and immune reactivity in cocaine-dependent men.

Authors:  Karen D Ersche; Cindy C Hagan; Dana G Smith; Sanja Abbott; P Simon Jones; Annemieke M Apergis-Schoute; Rainer Döffinger
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

7.  Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study.

Authors:  Sean G Kelly; Michael Plankey; Wendy S Post; Xiuhong Li; Ronald Stall; Lisa P Jacobson; Mallory D Witt; Lawrence Kingsley; Christopher Cox; Matthew Budoff; Frank J Palella
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.